|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6500 GBX | 0.00% |
|
0.00% | +23.81% |
| Market Cap | 54.1L 72.78L 63.6L 58.69L 1.02Cr 70Cr 1.04Cr 7.02Cr 2.76Cr 34Cr 2.73Cr 2.67Cr 118.17Cr | P/E 2024 |
-1.69x | P/E 2025 | -3.09x |
|---|---|---|---|---|---|
| Enterprise Value | 43.31L 58.26L 50.91L 46.98L 81.62L 56Cr 83.43L 5.62Cr 2.21Cr 27Cr 2.19Cr 2.14Cr 95Cr | EV / Sales 2024 |
19,86,57,512x | EV / Sales 2025 | 45,29,41,079x |
| Free-Float |
58.51% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Thalia Therapeutics Plc
| 1 month | +13.04% | ||
| 3 months | +13.04% | ||
| 6 months | +36.84% | ||
| Current year | +23.81% |
| 1 week | 0.6 |  | 0.7 |
| 1 month | 0.55 | | 0.7 |
| Current year | 0.4 | | 0.95 |
| 1 year | 0.35 | | 1 |
| 3 years | 0.35 | | 2.1 |
| 5 years | 0.35 | | 10.43 |
| 10 years | 0.35 | | 35.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Solomon
CEO | Chief Executive Officer | 66 | 24/02/2026 |
Rachel Schiller
COO | Chief Operating Officer | - | - |
Fiona McLaughlin
CTO | Chief Tech/Sci/R&D Officer | 56 | 27/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Cairns
BRD | Director/Board Member | 48 | 14/07/2020 |
| Chairman | 59 | 01/08/2023 | |
| Director/Board Member | 81 | 09/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/11/24 | Free | Chairman | 30,00,000 | 0.7599% | ||
| 28/11/24 | Free | Director | 30,00,000 | 0.7599% | ||
| 28/11/24 | Free | Founder | 60,00,000 | 1.5198% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +73.33% | -58.06% | 72.78L | |
| -7.17% | -4.39% | +45.51% | +79.00% | 5.21TCr | |
| +0.24% | -1.54% | +53.22% | +71.85% | 5.38TCr | |
| +0.80% | -6.31% | +3.98% | +423.29% | 2.35TCr | |
| -0.09% | -0.01% | -17.62% | -14.67% | 2.31TCr | |
| -5.95% | -2.58% | +30.67% | -9.58% | 1.94TCr | |
| -1.14% | +0.03% | +31.57% | -30.42% | 1.76TCr | |
| -5.16% | -7.00% | +168.44% | +306.37% | 1.52TCr | |
| -6.91% | -5.83% | +26.53% | +636.97% | 1.48TCr | |
| +0.43% | -1.03% | +24.63% | +191.40% | 1.41TCr | |
| Average | -2.50% | -2.36% | +44.03% | +159.61% | 2.34TCr | |
| Weighted average by Cap. | -2.80% | -2.36% | +40.12% | +144.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.01 0.01 0.01 0.01 0.01 0.94 0.01 0.09 0.04 0.46 0.04 0.04 1.59 | 0.01 0.01 0.01 0.01 0.01 0.94 0.01 0.09 0.04 0.46 0.04 0.04 1.59 |
| Net income | -10.59L -14.24L -12.45L -11.48L -19.95L -14Cr -20.4L -1.37Cr -53.99L -6.72Cr -53.49L -52.31L -23Cr | -12.05L -16.21L -14.17L -13.07L -22.71L -16Cr -23.22L -1.56Cr -61.46L -7.65Cr -60.88L -59.55L -26Cr |
| Net Debt | -6L -8L -7L -7L -11.8L -8.11Cr -12.06L -81.17L -31.93L -3.97Cr -31.63L -30.93L -14Cr | -10.79L -14.52L -12.69L -11.71L -20.34L -14Cr -20.79L -1.4Cr -55.05L -6.85Cr -54.53L -53.33L -24Cr |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | GBX 0.6500 | 0.00% | 1,04,84,669 |
| 16/26/16 | GBX 0.6500 | 0.00% | 8,68,813 |
| 15/26/15 | GBX 0.6500 | 0.00% | 8,65,584 |
| 14/26/14 | GBX 0.6500 | 0.00% | 3,40,970 |
| 13/26/13 | GBX 0.6500 | 0.00% | 7,57,214 |
- Stock Market
- Stocks
- THAT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
